⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 15, 2018ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)Open Access

Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast Cancer

Ivana Šestak Richard Buus Jack Cuzick Peter Dubsky Ralf Kronenwett Carsten Denkert Sean Ferree Dennis C. Sgroi Catherine A. Schnabel Frederick L. Baehner Elizabeth Mallon Mitch Dowsett

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

isrctn.com Identifier: ISRCTN18233230.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Šestak et al. (2018) studied this question.

synapsesocial.com/papers/69d7af6eb1cb92dd1bb8bb21 https://doi.org/10.1001/jamaoncol.2017.5524

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Sorting Out Breast-Cancer Gene SignaturesPrognostic Study · 2007 · 127 citations
2Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineRCT · 2016 · 811 citations
3Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)Prognostic Study · 2017 · 522 citations
4Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Original Research · 2015 · 1,828 citations
5Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast CancerPrognostic Study · 2011 · 740 citations

More related papers

Comparison of PAM50 Risk of Recurrence Score With Onco<i>type</i> DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy2013
Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy2016
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients2013

More from ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)

Neotropical puzzles: Assessing the role of spatial arrangement and human induced disturbances on the avian diversity of greenspace patchesSat,
From comparison to inclusion: post-Soviet immigrant parents’ perspectives on Canadian schoolingFri,